Oncolytic virus and inhibitor for NEDD8-activating enzyme pevonedistat: Promising combination for cancer therapy?

被引：0
|
作者：
Guo, Zong Sheng [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Dept Immunol, Buffalo, NY 14203 USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 11期
关键词：
D O I：
10.1016/j.ymthe.2023.10.008
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：3112 / 3114
页数：3
相关论文
共 50 条
  • [1] PEVONEDISTAT, A FIRST-IN-CLASS NEDD8-ACTIVATING ENZYME INHIBITOR, IS A POTENT INHIBITOR OF HEPATITIS B VIRUS
    Sekiba, Kazuma
    Otsuka, Motoyuki
    Koike, Kazuhiko
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1194 - S1194
  • [2] Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVA51 oncolytic virotherapy
    Wong, Boaz
    Bergeron, Anabel
    Maznyi, Glib
    Ng, Kristy
    Jirovec, Anna
    Birdi, Harsimrat K.
    Serrano, Daniel
    Spinelli, Marcus
    Thomson, Max
    Taha, Zaid
    Alwithenani, Akram
    Chen, Andrew
    Lorimer, Ian
    Vanderhyden, Barbara
    Arulanandam, Rozanne
    Diallo, Jean -Simon
    [J]. MOLECULAR THERAPY, 2023, 31 (11) : 3176 - 3192
  • [3] An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
    Soucy, Teresa A.
    Smith, Peter G.
    Milhollen, Michael A.
    Berger, Allison J.
    Gavin, James M.
    Adhikari, Sharmila
    Brownell, James E.
    Burke, Kristine E.
    Cardin, David P.
    Critchley, Stephen
    Cullis, Courtney A.
    Doucette, Amanda
    Garnsey, James J.
    Gaulin, Jeffrey L.
    Gershman, Rachel E.
    Lublinsky, Anna R.
    McDonald, Alice
    Mizutani, Hirotake
    Narayanan, Usha
    Olhava, Edward J.
    Peluso, Stephane
    Rezaei, Mansoureh
    Sintchak, Michael D.
    Talreja, Tina
    Thomas, Michael P.
    Traore, Tary
    Vyskocil, Stepan
    Weatherhead, Gabriel S.
    Yu, Jie
    Zhang, Julie
    Dick, Lawrence R.
    Claiborne, Christopher F.
    Rolfe, Mark
    Bolen, Joseph B.
    Langston, Steven P.
    [J]. NATURE, 2009, 458 (7239) : 732 - U67
  • [4] An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
    Teresa A. Soucy
    Peter G. Smith
    Michael A. Milhollen
    Allison J. Berger
    James M. Gavin
    Sharmila Adhikari
    James E. Brownell
    Kristine E. Burke
    David P. Cardin
    Stephen Critchley
    Courtney A. Cullis
    Amanda Doucette
    James J. Garnsey
    Jeffrey L. Gaulin
    Rachel E. Gershman
    Anna R. Lublinsky
    Alice McDonald
    Hirotake Mizutani
    Usha Narayanan
    Edward J. Olhava
    Stephane Peluso
    Mansoureh Rezaei
    Michael D. Sintchak
    Tina Talreja
    Michael P. Thomas
    Tary Traore
    Stepan Vyskocil
    Gabriel S. Weatherhead
    Jie Yu
    Julie Zhang
    Lawrence R. Dick
    Christopher F. Claiborne
    Mark Rolfe
    Joseph B. Bolen
    Steven P. Langston
    [J]. Nature, 2009, 458 : 732 - 736
  • [5] Immunomodulatory Effects of Pevonedistat, a NEDD8-Activating Enzyme (NAE) Inhibitor, in Chronic Lymphocytic Leukemia (CLL)
    Best, Scott R.
    Kittai, Adam
    Rowland, Taylor
    Bruss, Nur
    Spurgeon, Stephen E.
    Berger, Allison
    Moran, Amy
    Danilov, Alexey V.
    [J]. BLOOD, 2018, 132
  • [6] Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
    Swords, Ronan T.
    Coutre, Steven
    Maris, Michael B.
    Zeidner, Joshua F.
    Foran, James M.
    Cruz, Jose
    Erba, Harry P.
    Berdeja, Jesus G.
    Tam, Wayne
    Vardhanabhuti, Saran
    Pawlikowska-Dobler, Iwona
    Faessel, Helene M.
    Dash, Ajeeta B.
    Sedarati, Farhad
    Dezube, Bruce J.
    Faller, Douglas V.
    Savona, Michael R.
    [J]. BLOOD, 2018, 131 (13) : 1415 - 1424
  • [7] Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)
    Wong, Kit Man
    Micel, Lindsey N.
    Selby, Heather M.
    Tan, Aik Choon
    Pitts, Todd M.
    Bagby, Stacey M.
    Spreafico, Anna
    Klauck, Peter J.
    Blakemore, Stephen J.
    Smith, Peter F.
    McDonald, Alice
    Berger, Allison
    Tentler, John J.
    Eckhardt, S. Gail
    [J]. INVESTIGATIONAL NEW DRUGS, 2017, 35 (01) : 11 - 25
  • [8] Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo
    Czuczman, Natalie M.
    Barth, Matthew J.
    Gu, Juan
    Neppalli, Vishala
    Mavis, Cory
    Frys, Sarah E.
    Hu, Qiang
    Liu, Song
    Klener, Pavel
    Vockova, Petra
    Czuczman, Myron S.
    Hernandez-Ilizaliturri, Francisco J.
    [J]. BLOOD, 2016, 127 (09) : 1128 - 1137
  • [9] Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors
    Zhou, Xiaofei
    Richardson, Debra L.
    Dowlati, Afshin
    Goel, Sanjay
    Sahebjam, Solmaz
    Strauss, James
    Chawla, Sant
    Wang, Ding
    Mould, Diane R.
    Samnotra, Vivek
    Faller, Douglas, V
    Venkatakrishnan, Karthik
    Gupta, Neeraj
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (03): : 257 - 266
  • [10] Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)
    Kit Man Wong
    Lindsey N. Micel
    Heather M. Selby
    Aik Choon Tan
    Todd M. Pitts
    Stacey M. Bagby
    Anna Spreafico
    Peter J. Klauck
    Stephen J. Blakemore
    Peter F. Smith
    Alice McDonald
    Allison Berger
    John J. Tentler
    S. Gail Eckhardt
    [J]. Investigational New Drugs, 2017, 35 : 11 - 25
12345